Role for interleukin-6 in COPD-related pulmonary hypertension. - Wikidata - awgldk - TriplyDB

Role for interleukin-6 in COPD-related pulmonary hypertension.

Role for interleukin-6 in COPD-related pulmonary hypertension.

http://www.wikidata.org/entity/Q45893801

about

Immune and inflammatory mechanisms in pulmonary arterial hypertension Inflammatory cytokines in pulmonary hypertension Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury Megakaryocytic leukemia 1 (MKL1) regulates hypoxia induced pulmonary hypertension in rats Gender, Estrogen, and Obliterative Lesions in the Lung.Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.Plasma C-reactive protein and endothelin-1 level in patients with chronic obstructive pulmonary disease and pulmonary hypertension.Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis.Oxygen therapy for COPD.Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.Obesity-related pulmonary arterial hypertension in rats correlates with increased circulating inflammatory cytokines and lipids and with oxidant damage in the arterial wall but not with hypoxia Relationship between coronary artery disease and pulmonary arterial pressure in patients with chronic obstructive pulmonary disease.HMGB1 promotes the development of pulmonary arterial hypertension in rats.Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension Pulmonary Hypertension Secondary to COPD.Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials.Pulmonary hypertension in parenchymal lung disease.Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP).Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease.Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study.Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD Update on pulmonary hypertension complicating chronic obstructive pulmonary disease Gene polymorphisms and chronic obstructive pulmonary disease.Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.Pulmonary hypertension in a stable community-based COPD population.

P2860

Q26851508-533C2F9F-50ED-4017-B151-4E481499138D Q27007510-D38CEC31-7254-4B97-B1B6-3A9CD63AC9AC Q27329908-246EC452-DB86-4FEB-B98F-006A2994A7B3 Q28541108-7C9C82C6-4F0D-4E9E-AF6F-46C98BA73026 Q33567156-FAC0E99C-7E36-419E-A5AA-DE40B423286B Q33681073-6D7FCBF9-8D88-4C35-99DE-943CF3D3117D Q33738592-BCA79F9E-395D-493D-A616-7F7A938B265C Q33764990-622459FA-3D73-4E41-88DF-FE2571E3F6A1 Q33765096-FCE8DCA8-8A97-430B-80EB-A623259628EF Q33859158-7DACE859-F0D0-49E7-A9C1-C1190E335F67 Q33920050-6946AF43-F677-46D0-89BB-8A3D2C55230A Q34159759-C7F423D8-96B6-4A51-B1D2-13C5EFCC0C48 Q34196738-E4F15C5B-9C67-4A25-A398-D945F0F9EA1F Q34250971-A5329EE0-4F45-46B8-84C5-F8DA0D6F1128 Q34303086-EB4C8183-E875-424D-97ED-B952D4727D58 Q34425006-4F4D75AF-F80A-449C-92E7-7CD71940995C Q34628625-5E2453C5-A47C-4298-90FF-623C759ACD10 Q34665155-83169A02-1328-43FA-97C0-DDCE78782900 Q34782576-C86123AA-7BDB-4383-B968-E9F83FF7A095 Q35017450-D009C33A-6446-46A5-8A85-BACA3523C3CA Q35208059-8C47FEA0-CA27-4EFB-A870-F8EC37FF2802 Q35227277-D60750A8-1314-4D6A-851D-E2391C1E44EE Q35644609-2D49C425-DBDA-4403-ACE3-1B8225220664 Q36185917-5FA796FC-00A0-498B-BEC7-F81F216B1A71 Q36221051-2B543BF5-8E3A-446A-9642-53E53ED544AD Q36228135-29C97DF9-5193-4568-8F5E-A9FC410A7BD6 Q36328903-FBACA773-A2EF-40B6-B147-068A9DD44808 Q36406495-01921F85-978C-49B8-A60D-45D93B61EFA8 Q36608217-B330466E-D7FD-49A2-BE70-BF17F22831CF Q36676088-93D12906-F703-4B34-A652-3FC4ECDE5CB5 Q36709815-043FD40B-2D7C-4D04-972B-D25D63A95A71 Q36832901-4319FC05-5F7D-4F4C-99B0-FAA19051FEB7 Q37248994-B9BDC114-12A6-499F-A968-9E715D301115 Q37304910-680F37DE-97F6-487D-B7B6-453D58FDACA9 Q37367652-D8D805FD-B894-4E3D-8D3A-D6ECC4FA1AD7 Q37562317-6EAEC84B-FFAD-4D70-8716-4CDB65231EAF Q37636173-2AF791B6-9921-4A1B-8078-B0E109C85B19 Q37707674-4A4127B0-E666-447D-8A63-C5F6DC3CBB27 Q37730814-F07C9B26-9A6E-40FE-89FE-7F1C537420D1 Q37911350-2A439507-0E4A-4ED4-B465-1FEF24413099

P2860

Role for interleukin-6 in COPD-related pulmonary hypertension.

http://www.wikidata.org/entity/Q45893801

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Role for interleukin-6 in COPD-related pulmonary hypertension.

@en

Role for interleukin-6 in COPD-related pulmonary hypertension.

@nl

type

label

Role for interleukin-6 in COPD-related pulmonary hypertension.

@en

Role for interleukin-6 in COPD-related pulmonary hypertension.

@nl

prefLabel

Role for interleukin-6 in COPD-related pulmonary hypertension.

@en

Role for interleukin-6 in COPD-related pulmonary hypertension.

@nl

P1433

Q45893801-F5164178-A3B5-473F-8645-BDDAB84631BA

P1476

Q45893801-EABC65EF-8355-487C-9E06-733C56F74C43

P2093

Q45893801-02582567-6A14-41ED-8355-07A1B9D3A594

Q45893801-219A1D29-7CC0-4C20-8ED1-80CC84910887

Q45893801-3660D4A1-CC1B-460E-A83B-F4E6C023CDC4

Q45893801-58E8364D-C2E7-4ABE-B0F0-BF1FEBAC1F27

Q45893801-5DA80A9A-EC2E-4754-BA1B-0613E7BAB664

Q45893801-7183E787-D5AA-480D-AAAB-629356FA94C7

Q45893801-7606F5BF-B768-4F1B-9AD2-13730B569D5B

Q45893801-A7ADE4E0-3D81-444C-BC70-2139C8B159D1

Q45893801-E6AD528D-F58C-46DA-AA30-EE97FE53FAAA

P304

Q45893801-E7FAE1FE-7494-404F-B816-DA559AFEEFAA

P31

Q45893801-58F5515E-A068-4667-940D-A3A30225E950

P356

Q45893801-17FC03C0-469A-403D-907D-91AE2BC85D0D

P407

Q45893801-644A0302-90AD-42F6-BAC9-2CD417F0DFB7

P433

Q45893801-9C9F6DDA-6EFD-4ADC-9092-A2FCAFC6C55C

P478

Q45893801-F66C1588-69EE-412A-A234-C705E8190AF4

P50

Q45893801-0BED059E-B41F-4608-A02B-C3E7F617AD9F

Q45893801-71E9C815-691D-4691-AADA-A4E8D39C7CB3

Q45893801-7CD0EF31-AE6A-448E-8692-4C889A2143F5

Q45893801-858A47ED-CE9E-46F0-AFBC-18C4E92F0CC1

P577

Q45893801-2B6DA84E-474D-4D1C-975F-097F49B890B6

P5875

Q45893801-916353CB-A552-481D-8258-B105F8672283

P698

Q45893801-C6BA8B12-5808-4139-8E99-3F9A167997E3

P921

Q45893801-6137bf2d-4740-4879-9379-8ab5853bd682

P356

P1433

P1476

Role for interleukin-6 in COPD-related pulmonary hypertension.

@en

P2093

Ari Chaouat

http://www.w3.org/2001/XMLSchema#string

Benjamin Sztrymf

http://www.w3.org/2001/XMLSchema#string

Bruno Housset

http://www.w3.org/2001/XMLSchema#string

Christian Brandt

http://www.w3.org/2001/XMLSchema#string

Emmanuel Weitzenblum

http://www.w3.org/2001/XMLSchema#string

Laurent Savale

http://www.w3.org/2001/XMLSchema#string

Matthieu Canuet

http://www.w3.org/2001/XMLSchema#string

Saadia Eddahibi

http://www.w3.org/2001/XMLSchema#string

Serge Adnot

http://www.w3.org/2001/XMLSchema#string

P304

678-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.08-2420

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Le Corvoisier

Christos Chouaid

P577

2009-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24260446

http://www.w3.org/2001/XMLSchema#string

P698

19349390

http://www.w3.org/2001/XMLSchema#string

P921